Associate Director, Investor Relations

Key Responsibilities

• Support execution of Beam’s investor relations strategy, including proactive engagement with buy-side and sell-side investors.
• Help manage investor targeting, outreach, and meeting coordination for one-on-ones, conferences, and non-deal roadshows.
• Track investor sentiment, ownership trends, and peer activity to inform outreach strategy and positioning.
• Serve as a secondary point of contact for inbound investor and analyst inquiries.
• Support continuous improvement of IR best practices and infrastructure.
• Prepare key disclosures and quarterly earnings materials, including scripts, slide decks, Q&A documents, and press releases.
• Ensure accuracy, consistency, and compliance across external disclosures in coordination with legal and finance.
• Manage internal consensus models.
• Work cross-functionally with R&D, Clinical Development, Regulatory, and Commercial teams to: stay current on program updates and key milestones; translate technical data into clear, investor-relevant narratives; and support investor-facing materials related to clinical data readouts, regulatory updates, and pipeline evolution.
• Help refine and maintain Beam’s corporate narrative as the company evolves from a clinical-stage to commercial-stage biotech.
• Aid in message testing and preparation of executive spokespeople.
• Manage updates to Beam’s investor website and coordinate with Corporate Communications on broader digital and website strategy and content.

Required Qualifications

• 5–8 years of experience in investor relations, equity research, investment banking, corporate finance, or strategic communications, with meaningful exposure to public biotechnology or life sciences companies.
• Strong understanding of capital markets, public company disclosure requirements, and investor expectations.
• Ability to synthesize complex scientific, clinical, and financial information into clear, concise messaging.
• Prior experience supporting a pipeline-driven biotech company with multiple clinical programs.
• Exposure to companies approaching or undergoing a transition to commercial stage.
• Familiarity with gene editing, genetic medicine, or other advanced therapeutic modalities.
• Experience interacting directly with investors or analysts.

Preferred Qualifications

• Prior experience supporting a pipeline-driven biotech company with multiple clinical programs.
• Exposure to companies approaching or undergoing a transition to commercial stage.
• Familiarity with gene editing, genetic medicine, or other advanced therapeutic modalities.
• Experience interacting directly with investors or analysts.